Pharmaron Beijing Co (SZSE:300759) Operating Cash Flow per Share : ¥1.67 (TTM As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Pharmaron Beijing Co Operating Cash Flow per Share?

Pharmaron Beijing Co's operating cash flow per share for the three months ended in Mar. 2024 was ¥0.42. Pharmaron Beijing Co's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1.67.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Pharmaron Beijing Co was 45.70% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 18.80% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 21.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Pharmaron Beijing Co's Operating Cash Flow per Share or its related term are showing as below:

SZSE:300759' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: 18.8 Med: 24.1 Max: 45
Current: 18.8

During the past 10 years, Pharmaron Beijing Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 45.00% per year. The lowest was 18.80% per year. And the median was 24.10% per year.

SZSE:300759's 3-Year OCF Growth Rate is ranked better than
67.18% of 1240 companies
in the Biotechnology industry
Industry Median: 3.55 vs SZSE:300759: 18.80

Pharmaron Beijing Co Operating Cash Flow per Share Historical Data

The historical data trend for Pharmaron Beijing Co's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmaron Beijing Co Operating Cash Flow per Share Chart

Pharmaron Beijing Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

0.63

0.92

1.13

1.21

1.55

Pharmaron Beijing Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Operating Cash Flow per Share	Get a 7-Day Free Trial															0.30	0.42	0.42	0.41	0.42

Competitive Comparison of Pharmaron Beijing Co's Operating Cash Flow per Share

For the Biotechnology subindustry, Pharmaron Beijing Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmaron Beijing Co's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharmaron Beijing Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Pharmaron Beijing Co's Price-to-Operating-Cash-Flow falls into.

Pharmaron Beijing Co Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Pharmaron Beijing Co's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	2753.539	/	1775.248
	=	1.55

Pharmaron Beijing Co's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Mar. 2024 )	=	Cash Flow from Operations (Q: Mar. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
	=	745.631	/	1776.255
	=	0.42

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.67

Pharmaron Beijing Co Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Pharmaron Beijing Co's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmaron Beijing Co (SZSE:300759) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmaron Beijing Co Ltd (SZSE:300759) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

03759:Hong Kong 17Q1:Germany

Address

No. 248 Queen’s Road East, 40th Floor, Dah Sing Financial Centre, Hong Kong, HKG

Website

https://www.pharmaron.com

Pharmaron Beijing Co Ltd is a research and development service company supporting the life science industry. The company offers drug research and development service capabilities, ranging from synthetic, medicinal and analytical chemistry, biology, DMPK, pharmacology, drug safety assessment, radiochemistry and isotopically labelled metabolism, chemical and pharmaceutical development to clinical development. Its operating segment includes Laboratory services; CMC (small molecule CDMO) services; Clinical development services and biologics and CGT services. The company generates maximum revenue from Laboratory services segment.

Pharmaron Beijing Co (SZSE:300759) Headlines

No Headlines